340B Compliance Review

IndustryHealth System
ProblemThe client requested a gap analysis to identify any issues that needed to be addressed in the management controls, processes, and procedures to make sure that the health system was in compliance with 340B Drug Pricing Program regulations.
PHSI SolutionA compliance audit was conducted including onsite interviews, review of policies and procedures, and management controls. This review enabled PHSI to recommend operational changes to their policies and procedures along with implementing feedback mechanisms for better management controls of the end-to-end process.
ResultsPHSI provided recommendations that reduced the audit risk to the health system when HRSA conducts an audit analyzing the health systems compliance with 340B regulations.